GLPG-4586

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGLPG-4586
Drug Alias NameIdiopathic pulmonary fibrosis therapy (Galapagos)fibrosis therapy (Fibrocor)GLPG-4586
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsFibrosisIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFibrocor Therapeutics LP
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFibrocor Therapeutics LPGalapagos Nv
Active IndicationsN/A
Inactive IndicationsFibrosisIdiopathic Pulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A